InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: fred198484 post# 17055

Friday, 09/01/2017 7:06:58 PM

Friday, September 01, 2017 7:06:58 PM

Post# of 233264

Since the combo trial is apparently critical to the future of CYDY, there has to be some concern as long as the company has not shed any light on what is going on.



The company released a PR saying exactly what is going on. "The U.S. Food and Drug Administration has set a meeting on October 17 to discuss the next steps in CytoDyn’s efforts towards the analysis of primary efficacy endpoint and filing of a Biologics License Application for PRO 140."

That still confuses you? They didn't say the FDA set a meeting to discuss their concerns about the trial, or possibly extending it, but somehow you read that into it?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News